Provided by Tiger Trade Technology Pte. Ltd.

GraniteShares YieldBoost HIMS ETF

5.39
-0.0300-0.55%
Post-market: 5.390.00000.00%16:10 EDT
Volume:4K
Turnover:20.81K
Market Cap:646.20K
PE:- -
High:5.42
Open:5.41
Low:5.38
Close:5.42
52wk High:25.79
52wk Low:5.27
Shares:120.00K
Float Shares:120.00K
Volume Ratio:1.15
T/O Rate:3.21%
Dividend:8.65
Dividend Rate:160.62%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Sector Update: Healthcare Stocks Edge Lower in Afternoon Trading

MT Newswires Live
·
Jul 30

Hims & Hers Says FTC Lawsuit Disregards Substantial Evidence We Provided the Agency During Investigation

Reuters
·
Jul 30

Hims & Hers Health on FTC Lawsuit : We are Confident in Our Position and Will Vigorously Defend Ourselves Against These Baseless Claims

THOMSON REUTERS
·
Jul 30

Rpt: Hims & Hers on FTC Lawsuit: Lawsuit Disregards Substantial Evidence We Provided the FTC During Its Nearly Three-Year Investigation

THOMSON REUTERS
·
Jul 30

FTC Suing Hims & Hers Health for Allegedly Sending User Info to Meta and Snap, Reuters Reports

MT Newswires Live
·
Jul 30

Hims & Hers Shares Down 12.2%; Reuters Reports US FTC Sues Co for Sending User Health Info to Meta, Snap

THOMSON REUTERS
·
Jul 30

US FTC Suing Hims & Hers for Sending User Health Info to Meta, Snap

Reuters
·
Jul 30

Exclusive - U.S. Federal Trade Commission is Suing Hims & Hers over Billing, Cancellation and Privacy Practices, FTC Spokesperson Says

THOMSON REUTERS
·
Jul 30

Hims & Hers Health (HIMS) Receives a Hold from Truist Financial

TIPRANKS
·
Jul 29

Is Today’s Dip a Buying Opportunity for Hims & Hers Health (HIMS) Stock?

TIPRANKS
·
Jul 25

Hims & Hers falls -10.3%

TIPRANKS
·
Jul 25

Truist Raises Price Target on Hims & Hers Health to $27 From $23, Keeps Hold Rating

MT Newswires Live
·
Jul 24

Hims & Hers Health Inc : Truist Securities Raises Target Price to $27 from $23

THOMSON REUTERS
·
Jul 24

Moderately bullish activity in Hims and Hers Health with shares up 3.39%

TIPRANKS
·
Jul 24

Hims & Hers Health is Maintained at Neutral by Citigroup

Dow Jones
·
Jul 24

FDA Advisers Back First Four of Seven Unapproved Peptides Under Review for Looser Rules

Reuters
·
Jul 24

Why Is Hims & Hers Health Stock Surging on Thursday?

Benzinga
·
Jul 24

Hims Gains After FDA Panel Votes to Place Popularly Used Peptide Bpc-157 on Compounding List

Reuters
·
Jul 24

Hims & Hers Health Shares up 10% After FDA Advisory Panel Votes to Place Bpc-157 Peptide on Allowed Pharmacy Compounding List

THOMSON REUTERS
·
Jul 24

Hims & Hers Shares up 2% After Telehealth Firm Urged FDA to Broaden Access to Some Peptides in Panel Meeting

THOMSON REUTERS
·
Jul 23